Nexus Pharmaceuticals opened a $100 million manufacturing facility in July of 2021 in Pleasant Prairie, Wis.

AbCellera Biologics is planning to break ground in late 2021 on a manufacturing plant for therapeutic antibodies in Vancouver, British Columbia.

Moderna is initiating a major expansion of the 300,000-sf Moderna Technology Center in Norwood, Mass.

The International Society for Pharmaceutical Engineering has announced the 2021 Facility of the Year Awards category winners. The awards include:

Sanofi will begin construction in fall of 2021 on a vaccine manufacturing facility in Singapore.

FUJIFILM Diosynth Biotechnologies is planning to construct a $2 billion biopharmaceutical production facility in Holly Springs, N.C.

Vibalogics is creating a 110,000-sf facility for the production of oncolytic viruses, viral vector vaccines, and viral vector gene therapy products in Boxborough, Mass.

Civica Rx began construction in early 2021 on a $124.5 million pharmaceutical manufacturing center in Petersburg, Va.

The Massachusetts Center for Advanced Biological Innovation and Manufacturing is planning to create a 40,000-sf facility in Watertown, Mass.

Thermo Fisher Scientific is expanding its global production capacity for vaccines, medicines, and biologic therapies.